{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T07:40:43Z","timestamp":1772264443629,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jval.2021.10.002","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T00:41:42Z","timestamp":1639096902000},"page":"954-964","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Optimizing the Design of a Repeated Fecal Immunochemical Test Bowel Cancer Screening Programme With a Limited Endoscopy Capacity From a Health Economic Perspective"],"prefix":"10.1016","volume":"25","author":[{"given":"Sophie","family":"Whyte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chloe","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim","family":"Chilcott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Kearns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jval.2021.10.002_bib1","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1136\/gutjnl-2018-317293","article-title":"Performance of colorectal cancer screening in the European Union Member States: data from the second European screening report","volume":"68","author":"Senore","year":"2019","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.jval.2021.10.002_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-017186","article-title":"Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England","volume":"7","author":"Murphy","year":"2017","journal-title":"BMJ Open"},{"issue":"9","key":"10.1016\/j.jval.2021.10.002_bib4","doi-asserted-by":"crossref","first-page":"e547","DOI":"10.1111\/j.1463-1318.2012.03014.x","article-title":"Reappraisal of the options for colorectal cancer screening in England","volume":"14","author":"Whyte","year":"2012","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.jval.2021.10.002_bib5","author":"Whyte"},{"issue":"suppl 5","key":"10.1016\/j.jval.2021.10.002_bib6","doi-asserted-by":"crossref","first-page":"v6","DOI":"10.1136\/gut.51.suppl_5.v6","article-title":"British Society for Gastroenterology, Association of Coloproctology for Great Britain and Ireland. Surveillance guidelines after removal of colorectal adenomatous polyps","volume":"51","author":"Atkin","year":"2002","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.jval.2021.10.002_bib7","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1177\/0272989X10384738","article-title":"Bayesian calibration of a natural history model with application to a population model for colorectal cancer","volume":"31","author":"Whyte","year":"2011","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jval.2021.10.002_bib8","author":"Whyte"},{"issue":"10","key":"10.1016\/j.jval.2021.10.002_bib9","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.jval.2019.06.005","article-title":"External validation of a colorectal cancer model against screening trial long-term follow-up data","volume":"22","author":"Thomas","year":"2019","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2021.10.002_bib11","series-title":"Unit Costs of Health and Social Care 2015","author":"Curtis","year":"2015"},{"issue":"9","key":"10.1016\/j.jval.2021.10.002_bib12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/gutjnl-2015-310691","article-title":"Increased uptake and improved outcomes of bowel cancer screening with a faecal immunochemical test: results from a pilot study within the national screening programme in England","volume":"66","author":"Moss","year":"2017","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.jval.2021.10.002_bib13","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1038\/bjc.2014.469","article-title":"Guaiac faecal occult blood test performance at initial and repeat screens in the English Bowel Cancer Screening Programme","volume":"111","author":"Kearns","year":"2014","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.jval.2021.10.002_bib14","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/gut.2008.162883","article-title":"Results from the first three rounds of the Scottish demonstration pilot of FOBT screening for colorectal cancer","volume":"58","author":"Steele","year":"2009","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.jval.2021.10.002_bib15","doi-asserted-by":"crossref","first-page":"S759","DOI":"10.1016\/S0016-5085(16)32575-6","article-title":"Mo1711 sensitivity of repeated fecal immunochemical testing (FIT) over time: does each \u201cbite at the apple\u201d stand the same chance?","volume":"150","author":"Ladabaum","year":"2016","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.jval.2021.10.002_bib16","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1002\/cncr.29952","article-title":"Nonbleeding adenomas: evidence of systematic false-negative fecal immunochemical test results and their implications for screening effectiveness\u2014a modeling study","volume":"122","author":"van der Meulen","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.jval.2021.10.002_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/672410","article-title":"Interval cancers in a population-based screening program for colorectal cancer in Catalonia, Spain","volume":"2015","author":"Garcia","year":"2015","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.jval.2021.10.002_bib19","author":"Brown"},{"issue":"23","key":"10.1016\/j.jval.2021.10.002_bib20","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1093\/jnci\/djr385","article-title":"Fecal occult blood testing when colonoscopy capacity is limited","volume":"103","author":"Wilschut","year":"2011","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.jval.2021.10.002_bib21","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1136\/gutjnl-2015-310102","article-title":"Immunochemical faecal occult blood testing to screen for colorectal cancer: can the screening interval be extended?","volume":"66","author":"Haug","year":"2017","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.jval.2021.10.002_bib22","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1136\/gutjnl-2017-314862","article-title":"Can the performance of a quantitative FIT-based colorectal cancer screening programme be enhanced by lowering the threshold and increasing the interval?","volume":"67","author":"Digby","year":"2018","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.jval.2021.10.002_bib23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/gutjnl-2011-301583","article-title":"Random comparison of repeated faecal immunochemical testing at different intervals for population-based colorectal cancer screening","volume":"62","author":"van Roon","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.jval.2021.10.002_bib24","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2147\/CMAR.S153361","article-title":"The association between long-term conditions and uptake of population-based screening for colorectal cancer: results from two English cohort studies","volume":"10","author":"Kearns","year":"2018","journal-title":"Cancer Manag Res"},{"issue":"2","key":"10.1016\/j.jval.2021.10.002_bib25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/bjc.2017.375","article-title":"Risk-adjusted colorectal cancer screening using the FIT and routine screening data: development of a risk prediction model","volume":"118","author":"Cooper","year":"2018","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.jval.2021.10.002_bib26","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1136\/gutjnl-2013-305013","article-title":"Combining risk factors with faecal immunochemical test outcome for selecting CRC screenees for colonoscopy","volume":"63","author":"Stegeman","year":"2014","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.jval.2021.10.002_bib27","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1111\/jgh.15033","article-title":"Cost-effectiveness analysis of colorectal cancer screening using colonoscopy, fecal immunochemical test, and risk score","volume":"35","author":"Sekiguchi","year":"2020","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jval.2021.10.002_bib28","first-page":"1","article-title":"Cost-effectiveness of risk-stratified colorectal cancer screening based on polygenic risk: current status and future potential","volume":"4","author":"Naber","year":"2020","journal-title":"JNCI Cancer Spec"},{"issue":"1","key":"10.1016\/j.jval.2021.10.002_bib29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1158\/1055-9965.EPI-18-1123","article-title":"Cost-effectiveness of personalized screening for colorectal cancer based on polygenic risk and family history","volume":"29","author":"Cenin","year":"2020","journal-title":"Cancer Epidemiol Prev Biomark"},{"issue":"8","key":"10.1016\/j.jval.2021.10.002_bib30","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1158\/1940-6207.CAPR-20-0620","article-title":"The costs and benefits of risk-stratification for colorectal cancer screening based on phenotypic and genetic risk: a health economic analysis","volume":"14","author":"Thomas","year":"2021","journal-title":"Cancer Prev Res"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109830152101785X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109830152101785X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:26:49Z","timestamp":1761096409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109830152101785X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S109830152101785X"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2021.10.002","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing the Design of a Repeated Fecal Immunochemical Test Bowel Cancer Screening Programme With a Limited Endoscopy Capacity From a Health Economic Perspective","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2021.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}